Briefly, CD4 cell count, CD4/CD8 ratio and CD8-CD28+ cells were all comparable for both groups at the end of 4th STI, the end of ART (final stop), week 24 and week 48. The gene discussed is CD28; the disease is sexually transmitted disease.